Neogen's weak first quarter results, including flat revenue on a pro forma basis, have seriously damaged its growth stock reputation, leading to a major decline in the shares. The integration of 3M's ...

It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" In this series, we measure how swiftly a ...

Neogen's merger with 3M's Food Safety business resulted in a significant drop in its share price and a disappointing operating performance. The combination is struggling to show organic growth, shows ...

It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When judging a company's prospects, how ...